The Czech National Bank, the central bank of the Czech Republic, has established a $1 million digital asset portfolio pilot, with plans to hold Bitcoin, a stablecoin and tokenized asset.The Czech National Bank, the central bank of the Czech Republic, has established a $1 million digital asset portfolio pilot, with plans to hold Bitcoin, a stablecoin and tokenized asset.

Czech National Bank launches $1m crypto portfolio pilot

The Czech National Bank, the central bank of the Czech Republic, has established a $1 million digital asset portfolio pilot, with plans to hold Bitcoin, a stablecoin, and a tokenized asset.

Summary
  • Czech National Bank makes historic first Bitcoin buy by a central bank.
  • The CNB has purchased $1 million for its digital asset test portfolio, with Bitcoin, a stablecoin and tokenized asset.
  • The bank plans to use the portfolio to learn about blockchain processes, including trading and accounting.

The Czech National Bank announced on Nov. 13 that it would create a $1 million test portfolio for digital assets, calling it the first such move in history.

CNB’s pilot will include Bitcoin (BTC), a U.S. dollar stablecoin, and a tokenized deposit, with these purchases receiving the Bank Board’s seal of approval on October 30. 

Czech National Bank buys Bitcoin

According to details, adding Bitcoin and other digital assets to the central bank’s balance sheet is a historic move. It comes amid the realization that the institutions are increasingly embracing digital assets as investments. With future adoption across the global financial ecosystem on the cards, the CNB believes this is the time to test and learn. 

Specifically, the Czech central bank wants to use the portfolio as a test project to gain practical experience with blockchain-based processes, including holding digital assets. 

With BTC, a USD stablecoin, and a tokenized asset, the CNB has a portfolio structure that allows it to compare various types of digital assets. It also means the bank’s staff can learn about different properties, including settlement, trading, and auditing. The pilot eyes an in-house expertise framework that can be tapped into to pass learnt knowledge to other teams.

The public will get details of the pilot updates and CNB’s experience as the project proceeds, and an overall assessment in about two to three years.

However, there are no plans to increase the $1 million investment actively.  The CNB does not also intend to add Bitcoin or cryptocurrencies to its international reserves.

Market Opportunity
Lorenzo Protocol Logo
Lorenzo Protocol Price(BANK)
$0.04979
$0.04979$0.04979
+5.59%
USD
Lorenzo Protocol (BANK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26